(NASDAQ: POAI) Predictive Oncology's forecast annual revenue growth rate of 157.59% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Predictive Oncology's revenue in 2025 is $1,379,086.On average, 1 Wall Street analysts forecast POAI's revenue for 2025 to be $62,203,045, with the lowest POAI revenue forecast at $62,203,045, and the highest POAI revenue forecast at $62,203,045. On average, 1 Wall Street analysts forecast POAI's revenue for 2026 to be $103,005,042, with the lowest POAI revenue forecast at $103,005,042, and the highest POAI revenue forecast at $103,005,042.
In 2027, POAI is forecast to generate $159,807,822 in revenue, with the lowest revenue forecast at $159,807,822 and the highest revenue forecast at $159,807,822.